This compound is a pharmaceutical intermediate designed as a DOTA-based bioconjugation building block. It features a maleimide group for selective coupling with thiol-containing biomolecules and multiple tert-butyl ester-protected carboxyl groups, enabling controlled deprotection and conjugation in research and manufacturing settings.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 1613382-10-7
Methyl 4-aminopyridine-3-carboxylate
pharmaceutical intermediate
1-Methanesulfonylpiperazine hydrochloride
pharmaceutical intermediate
(3S)-3-hydroxy-L-lysine
pharmaceutical intermediate
1-(4-fluorophenyl)piperazine hydrochloride
Pharmaceutical intermediate
DOTA-maleimido
bioconjugation reagent for targeted imaging
tert-butyl 2-[4-[2-[2-(2,5-dioxopyrrol-1-yl)ethylamino]-2-oxoethyl]-7,10-bis[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]-1,4,7,10-tetrazacyclododec-1-yl]acetate
AWBZYCMDPJWQKQ-UHFFFAOYSA-N
CC(C)(C)OC(=O)CN1CCN(CCN(CCN(CC1)CC(=O)OC(C)(C)C)CC(=O)OC(C)(C)C)CC(=O)NCCN2C(=O)C=CC2=O
—